Literature DB >> 22344984

Long-term outcomes following 282 consecutive cases of infrapopliteal PTA and association of risk factors with primary patency and limb salvage.

Fragiska Sigala1, Elissaios Kontis, Wolfang Hepp, Konstantinos Filis, John Melissas, Petros Mirilas.   

Abstract

We aimed to determine the long-term results after infrapopliteal PTA (primary patency, limb salvage, survival) and examine for association with risk factors (e.g. diabetes, infection, etc). We studied 268 patients with 282 critically ischemic limbs treated with PTA of at least one crural artery during a six-year period. Data included TASC II morphological classification of lesions and risk factors. Technical success rate was 97.2%, and overall mortality 0.7%. Patients with milder TASC lesions preserved primary patency longer than patients with more severe lesions. Similar results were obtained for limb salvage and survival. Fontaine stage, TASC class and postoperative infection of operated limb increased the risk for loss of primary patency and major amputation. Concomitant carotid stenosis was associated with loss of primary patency. Diabetes mellitus, preoperative ulcer or gangrene were associated with need of major amputation. PTA was a safe and effective treatment for CLI due to lesions of infrapopliteal vessels.

Entities:  

Mesh:

Year:  2012        PMID: 22344984     DOI: 10.1177/1538574411432161

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  Outcomes of infrapopliteal angioplasty for limb salvage based on the updated TASC II classification.

Authors:  Hong Kuan Kok; Hamed Asadi; Mark Sheehan; Frank P McGrath; Mark F Given; Michael J Lee
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

Review 2.  Endovascular techniques in limb salvage: infrapopliteal angioplasty.

Authors:  Joseph J Naoum; Elias J Arbid
Journal:  Methodist Debakey Cardiovasc J       Date:  2013-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.